Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

The DES Landscape and Bioabsorbable Scaffolds in 2017

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

Presenter: Daniel Burkhoff, Samir R. Kapadia, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Presenter: Giulio G. Stefanini, Stephan Windecker, Philip M. Urban

October 30, 2017

Presentation TCT 2017

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Evald H. Christiansen

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Pim A.L. Tonino

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Giulio G. Stefanini

October 29, 2017

Advertisement

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

The DES Landscape and Bioabsorbable Scaffolds in 2017

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content